Simultaneous production of interleukin 2, interleukin 4 and interferon-γ by activated human blood lymphocytes
✍ Scribed by Ulf Andersson; Jan Andersson; Anders Lindfors; Kathrin Wagner; Goran Möller; Christoph H. Heusser
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 924 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
When cultured with native or recombinant interleukin-2 (IL-2) human small agranular lymphocytes acquire the ability to kill various tumor targets. The development of these IL-2 activated killer (IAK) cells, also known as LAK, is observed in the absence of antigen or mitogen. Interferons are known to
Controversial data have been reported regarding the ability of peripheral blood T cells to secrete interferon-y (IFN-y) and interleukin-4 (IL-4) from atopic patients as compared to nonatopic healthy controls. In most of these studies, T cells in peripheral blood mononuclear cell preparations (PBMC)
This report initially reviews the progressive steps of research designed to build up a new, well-defined helper system triggering both the non-specific and the tumor-specific immune reactivity of a host bearing a tumor, in order to impair tumor growth. Tumor-specific T-helper lymphocytes were first